Hiraoka Y, Ogasawara T, Tajima Y, Yaguchi T, Watanabe A, Teruya K, Nagasaki K, Matsuyama W, Niwa M, Ozawa Y, Sato J : Spontaneous remission of Pneumocystis jirovecii pneumonia followed by severe pulmonary nocardiosis in a patient with HIV infection: A case report. Journal of Infection and Chemotherapy 31 (1): 102609, 2025
Kojima S, Inui N, Suzuki T, Tanaka K, Karayama M, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nishimoto K, Matsuura S, Hashimoto D, Matsui T, Asada K, Suda T : Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials. BMC Cancer 25(1): 1494, 2025
Mochizuki E, Matsuura S, Koshimizu N, Kojima S, Sakurai S, Kishimoto S, Niwa M, Watanuki M, Inaba R, Takuma S, Inoue Y, Karayama M, Inui N, Suda T : First-line durvalumab plus platinum-etoposide in Japanese patients with extensive-stage small-cell lung cancer. Cancer Treat Res Commun 44: 100972, 2025
Inoue Y, Kitahara Y, Karayama M, Asada K, Nishimoto K, Matsuura S, Hashimoto D, Fujii M, Matsui T, Inami N, Toyoshima M, Matsuda H, Ikeda M, Niwa M, Kaida Y, Sato M, Ito Y, Yasui H, Suzuki Y, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T : Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies. JTO Clin Res Rep. 6(8): 100847, 2025
Yasui H, Oishi K, Nihashi F, Furuhashi K, Fujisawa T, Inoue Y, Karayama M, Hozumi H, Suzuki Y, Enomoto N, Kojima S, Niwa M, Harada M, Kato M, Hashimoto D, Yokomura K, Koshimizu N, Toyoshima M, Shirai M, Shirai T, Inui N, Suda T : Factors associated with uncontrolled severe asthma in the biologic era. Respir Med 236:107881, 2025
Kojima S, Inoue Y, Karayama M, Hashimoto D, Asada K, Matsuura S, Imokawa S, Matsui T, Matsuda H, Inami N, Kaida Y, Sato J, Ito Y, Fujii M, Toyoshima M, Yasui H, Suzuki Y, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T : Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Receiving Systemic Therapy. Clinical Lung Cancer 2025 Oct 13:S1525-7304(25)00267-0. doi: 10.1016/j.cllc.2025.10.009., 2025
Takamori S, Shimokawa T, Osoegawa A, Abe M, Takumi Y, Sugawara S, Niho S, Goto Y, Okamoto H, Hotta K, Ozawa Y, Oizumi S, Yamamoto N, Mitsudomi T, Yamaguchi M: Clinical Outcomes and Safety of Concurrent Chemoradiotherapy in EGFR-Mutant Unresectable Stage III Non-Small Cell Lung Cancer. TO Clin Res Rep 100897. doi:10.1016/j.jtocrr.2025.100897., 2025
Ogasawara T, Hiraoka Y, Hosoya N, Sugiura M, Kishimoto E, Nagasaki K, Matsuyama W, Suzuki T, Niwa M, Ozawa Y, Ogiku M, Sato J: Parenterally administered amino acids decrease acute mortality in fasting patients with aspiration pneumonia: A retrospective study. Clin Nutr ESPEN 66: 221-225. doi: 10.1016/j.clnesp.2025.01.054.,2025
Osuga M, Ozawa Y, Akamatsu H, Shibaki R, Hayata A, Nakanishi M, Yamamoto N, Koh Y: Impact of Immediate Inflammatory Cytokines Elevation After Chemotherapy and Pembrolizumab in Advanced Non-Squamous NSCLC.第63回日本癌治療学会学術集会.2025.10.16（横浜，一般演題）
Ozawa Y, Kenmotsu H, Saito Y, Ninomiya K, Yamamoto N, Akdemir B, Uematsu S,Fukui A, Koto R, Fujiwara M, Iwao C, Bernatowicz K, Pous AJ, Kitagawa H, Yoshino I, Gemma A, Mitsudomi T : Radiomics Analysis for ILD Prediction in Stage III NSCLC Patients Treated with Durvalumab.第66回日本肺癌学会学術集会．2025.11.07（東京，一般演題）
Ogasawara T, Hiraoka Y, Miyazawa Y, Ogiku M, Nihashi T : Loss of erector spinae muscles after vertebral fracture inhibits recovery of activities of daily living in postoperative hip fracture patients. 47th ESPEN Congress, 2025.09.13 (Prague, 一般演題）
Hiraoka Y, Ogasawara T : Association between the geriatric nutritional risk index and erector spinae muscle mass in patients with aspiration pneumonia. 47th ESPEN Congress, 2025.09.13（Prague， 一般演題）
